Zhan Hangjun 4
4 · Kindred Biosciences, Inc. · Filed Jan 26, 2021
Insider Transaction Report
Form 4
Zhan Hangjun
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2021-01-22+6,250→ 46,076 total - Tax Payment
Common Stock
[F2]2021-01-22$4.93/sh−3,385$16,688→ 42,691 total - Tax Payment
Common Stock
[F2]2021-01-23$4.93/sh−3,385$16,688→ 39,306 total - Exercise/Conversion
Restricted Stock Units
[F1][F3]2021-01-22−6,250→ 6,250 total→ Common Stock (6,250 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]These shares are being surrendered to satisfy a tax withholding obligation of the reporting person.
- [F3]On January 22, 2018, the reporting person was granted 25,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Signature
/s/ Hangjun Zhan|2021-01-26